Urobiome Analysis in Interstitial Cystitis/Bladder Pain Syndrome Reveals Nuanced Differences Associated with Localized Pain
Open Access
- 20 June 2026
- journal article
- Published by Springer Nature in International Urogynecology Journal
- Vol. 37 (10) , 3585-3595
Abstract
Introduction and Hypothesis: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a prevalent chronic pain syndrome associated with functional urinary disorders. IC/BPS symptoms can be localized to the pelvic-region or have co-occurring widespread pain. Importantly, response to treatment depends on pain localization phenotype. The etiology of IC/BPS remains elusive, and whether bacteria contribute to IC/BPS pathophysiology remains uncertain. We hypothesized that the urobiome does not differentiate phenotypic presentations of IC/BPS. Methods: We used urine samples collected from a longitudinal randomized controlled trial of psychotherapy for individuals with IC/BPS to study the association of the urobiome and IC/BPS symptoms over time. Individuals provided urine samples at baseline, posttreatment, and at 5 months. We performed a secondary analysis on urine samples applying 16S rRNA sequencing and assigned bacterial taxonomy to amplicon sequence variants (ASVs) to characterize the urobiome. We compared urobiome diversity and stability over time, their associations with IC/BPS symptoms, and relationships with pain localization. Results: As validation of this dataset, we noted a strong influence of menopausal status and recent urinary tract infection on the composition of the urobiome. We did not detect widespread differences in the urobiome that correlated with an individuals’ pain localization or severity. Instead, we observed specific bacterial sequences that were altered in abundance in relation to symptomatology, such as reduced abundance of a Dialister ASV in persons with localized pelvic pain. Conclusions: Together, this dataset advances our understanding of the urobiome in IC/BPS and sets the stage for future studies on the urobiome and IC/BPS symptoms.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK118118)
- National Institute of Diabetes and Digestive and Kidney Diseases (P20DK123967)
- National Institute of Allergy and Infectious Diseases (F30AI169748)
- National Center for Advancing Translational Sciences (UL1TR002243)
This publication has 39 references indexed in Scilit:
- Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiomeCell Reports Medicine, 2022
- Clinical Phenotyping for Pain Mechanisms in Urologic Chronic Pelvic Pain Syndromes: A MAPP Research Network StudyThe Journal of Pain, 2022
- The effect of mindfulness-based stress reduction on the urinary microbiome in interstitial cystitisInternational Urogynecology Journal, 2021
- Urinary fungi associated with urinary symptom severity among women with interstitial cystitis/bladder pain syndrome (IC/BPS)World Journal of Urology, 2019
- Characterization of Whole Body Pain in Urological Chronic Pelvic Pain Syndrome at Baseline: A MAPP Research Network StudyJournal of Urology, 2017
- Prevalence of Symptoms of Bladder Pain Syndrome/Interstitial Cystitis Among Adult Females in the United StatesJournal of Urology, 2011
- Validation of a Modified National Institutes of Health Chronic Prostatitis Symptom Index to Assess Genitourinary Pain in Both Men and WomenUrology, 2009
- Urinary Tract Infection and Inflammation at Onset of Interstitial Cystitis/Painful Bladder SyndromeUrology, 2008
- Symptoms of Interstitial Cystitis, Painful Bladder Syndrome and Similar Diseases in Women: A Systematic ReviewJournal of Urology, 2007
- Is interstitial cystitis an infectious disease?Medical Hypotheses, 1994